Implants from the authorized, licensed pharmacist come with a license for their use to protect providers from
charges of contributory infringement of the patents that have claims directed to the use of naltrexone implants.
These patents are:
US Patent No. 5,789,411
– Improvements to rapid opioid detoxification
US Patent No. 6,004,962
– Rapid opioid detoxification
US Patent No. 6,203,813
– Pharmaceutical delivery device and method of preparation therefor
Patent Application
US Patent Application No. 20,100,311,704
- Pharmaceutical delivery systems for treatment of substance abuse and other addictions